IP Library Granted Patent US 7,863,327
Granted Patent B2
US 7,863,327 · App. 11/121,316 · Granted Jan 4, 2011

Therapeutic compounds and methods of use

Assignee: Trustees of Dartmouth College
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,863,327
App. No.
11/121,316
Granted
Jan 4, 2011
Kind
B2
Abstract

Compounds and methods useful for chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis.

Claims (18)

1. A compound having the formula:

wherein R 1 is a cyano group, R 2 is methyl, and R 3 is alkoxy.

2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

3. The pharmaceutical composition of claim 2 , wherein the composition is formulated as a hard or soft capsule, a tablet, a syrup, a suspension, a wafer, or an elixir.

4. The pharmaceutical composition of claim 3 , wherein the soft capsule of the composition is a gelatin capsule.

5. The pharmaceutical composition of claim 2 , wherein the composition further comprises a protective coating.

6. The pharmaceutical composition of claim 2 , wherein the composition further comprises an agent that delays absorption.

7. The pharmaceutical composition of claim 2 , wherein the composition further comprises an agent that enhances solubility or dispersibility.

8. A pharmaceutical composition comprising a compound of claim 1 and a liposome, wherein the compound is dispersed in the liposome.

9. A pharmaceutical composition comprising a compound of claim 1 , oil and water, wherein the compound is dispersed in an oil and water emulsion or a water and oil emulsion.

10. A compound having the following formula:

11. A method of treating a disorder, wherein the disorder is breast cancer, prostate cancer, colon cancer, brain cancer, melanoma, pancreatic cancer, ovarian cancer, leukemia, or bone cancer comprising administering to said subject a therapeutically effective dosage of a compound having the formula:

wherein R 1 is a cyano group, R 2 is methyl, and R 3 is alkoxy,

such that the disorder is treated.

12. The method of claim 11 , wherein the disorder is breast cancer, prostate cancer, colon cancer, brain cancer, melanoma, pancreatic cancer, ovarian cancer, leukemia, or bone cancer.

13. The method of claim 11 , wherein said subject is a mammal.

14. The method of claim 13 , wherein said mammal is a human.

15. A compound of the formula:

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 29, 2011
From: DARTMOUTH COLLEGE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027290/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2009
From: GRIBBLE, GORDON W.; HONDA, TADASHI; SPORN, MICHAEL B.; SUH, NANJOO
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 023462/0245 →
Continuity (6)
Continuation 1039537200 · Mar 24, 2003
Continuation 0992708100 · Aug 9, 2001
Division 0933500300 · Jun 17, 1999
Provisional Application 6009005300 · Jun 19, 1998
Related Publication 20050288363A1 · Dec 29, 2005
Related Publication 20080234368A9 · Sep 25, 2008